Clinical Trial Update: Evaluating Stereotactic Body Radiation Therapy for Oligometastatic Disease of the Bone [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating stereotactic body radiation therapy for oligometastatic disease of the bone; results were posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Cancer

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Bone Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-08-29